Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Courteney K Lai

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Blood|June 22, 2019
Message from the void: MRD analysis from ctDNAMichael Heuser, Courteney K Lai
Molecular Therapy. Methods & Clinical Development|July 1, 2017
Lentiviral Fluorescent Genetic Barcoding for Multiplex Fate Tracking of Leukemic CellsTobias Maetzig, Jens Ruschmann, Lea Sanchez Milde, et al.
Blood Advances|May 7, 2025
Clec12a is required for the pathogenesis of NUP98::NSD1 AMLSagarajit Mohanty, Fiorella Charles Cano, Razif Gabdoulline, et al.
Leukemia Research|December 7, 2010
Delineating domains and functions of NUP98 contributing to the leukemogenic activity of NUP98-HOX fusionsEric Yung, Sanja Sekulovic, Bob Argiropoulos, et al.
Current Cancer Drug Targets|June 21, 2016
Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug ScreeningAmit Sharma, Nidhi Jyotsana, Courteney K Lai, et al.
Blood Advances|January 4, 2018
A knock-in mouse strain facilitates dynamic tracking and enrichment of MEIS1Ping Xiang, Wei Wei, Nicole Hofs, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2017
A Lentiviral Fluorescent Genetic Barcoding System for Flow Cytometry-Based Multiplex TrackingTobias Maetzig, Jens Ruschmann, Courteney K Lai, et al.
Cancers|September 30, 2020
Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid LeukemiaSagarajit Mohanty, Nidhi Jyotsana, Amit Sharma, et al.
Plos One|November 18, 2014
Cell fate decisions in malignant hematopoiesis: leukemia phenotype is determined by distinct functional domains of the MN1 oncogeneCourteney K Lai, Yeonsook Moon, Florian Kuchenbauer, et al.
Cancer Cell|July 12, 2011
Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complexMichael Heuser, Haiyang Yun, Tobias Berg, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Blood|June 22, 2019
Message from the void: MRD analysis from ctDNAMichael Heuser, Courteney K Lai
Molecular Therapy. Methods & Clinical Development|July 1, 2017
Lentiviral Fluorescent Genetic Barcoding for Multiplex Fate Tracking of Leukemic CellsTobias Maetzig, Jens Ruschmann, Lea Sanchez Milde, et al.
Blood Advances|May 7, 2025
Clec12a is required for the pathogenesis of NUP98::NSD1 AMLSagarajit Mohanty, Fiorella Charles Cano, Razif Gabdoulline, et al.
Leukemia Research|December 7, 2010
Delineating domains and functions of NUP98 contributing to the leukemogenic activity of NUP98-HOX fusionsEric Yung, Sanja Sekulovic, Bob Argiropoulos, et al.
Current Cancer Drug Targets|June 21, 2016
Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug ScreeningAmit Sharma, Nidhi Jyotsana, Courteney K Lai, et al.
Blood Advances|January 4, 2018
A knock-in mouse strain facilitates dynamic tracking and enrichment of MEIS1Ping Xiang, Wei Wei, Nicole Hofs, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2017
A Lentiviral Fluorescent Genetic Barcoding System for Flow Cytometry-Based Multiplex TrackingTobias Maetzig, Jens Ruschmann, Courteney K Lai, et al.
Cancers|September 30, 2020
Targeted Inhibition of the NUP98-NSD1 Fusion Oncogene in Acute Myeloid LeukemiaSagarajit Mohanty, Nidhi Jyotsana, Amit Sharma, et al.
Plos One|November 18, 2014
Cell fate decisions in malignant hematopoiesis: leukemia phenotype is determined by distinct functional domains of the MN1 oncogeneCourteney K Lai, Yeonsook Moon, Florian Kuchenbauer, et al.
Cancer Cell|July 12, 2011
Cell of origin in AML: susceptibility to MN1-induced transformation is regulated by the MEIS1/AbdB-like HOX protein complexMichael Heuser, Haiyang Yun, Tobias Berg, et al.
Pageof 2